| 期刊簡介 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ANNALS OF NUCLEAR MEDICINE LetPub Score 5.2
50 ratings
Rate
Reputation 6.3 Influence 3.9 Speed 7.0 | ||||||||||||||||
| 期刊簡稱 | ANN NUCL MED | ||||||||||||||||
| ISSN | 0914-7187 | ||||||||||||||||
| E-ISSN | 1864-6433 | ||||||||||||||||
| h-index | 52 | ||||||||||||||||
| CiteScore |
| ||||||||||||||||
| 自引率 (2023-2024) | 8.00%自引率趨勢 | ||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||
| 官方網站 | https://www.springer.com/12149 | ||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/anme | ||||||||||||||||
| 開放訪問 | No | ||||||||||||||||
| 出版商 | Springer Singapore | ||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||
| 出版國/地區 | JAPAN | ||||||||||||||||
| 發行頻率 | 隔月刊行 | ||||||||||||||||
| 創刊年 | 1987 | ||||||||||||||||
| 每年文章數 | 64每年文章數趨勢 | ||||||||||||||||
| 黃金OA百分比 | 21.09% | ||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q2
| ||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0914-7187%5BISSN%5D | ||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||
| 競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [ANNALS OF NUCLEAR MEDICINE] 的評論 | 撰寫評論 |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 20:48:15 評論於 Due to the various factors that can affect the effectiveness of animal experiments or clinical treatments, unless the results obtained clearly show a synergistic effect greater than the sum of the efficacy of each drug, it is generally referred to as an additive effect  (0) 讚！ | 维尔娜菲茨杰拉德  |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 11:47:23 評論於 ORCID is the Open Researcher and Contributor ID. The ORCID ID is a unique and persistent academic identifier for contributors, which helps distinguish authors from other researchers and also records all related research activities of the author. To link an ORCID ID to a submission, one needs to log into the author's account and make the association in the account information section (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-26 11:02:47 評論於 How to determine whether two drugs exhibit a synergistic effect or an additive effect? (0) 讚！ | 平原文波 |
| 作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-26 09:35:01 評論於 How to add ORCIDID if it is not provided when the article is published? (0) 讚！ | 深渊兴业 |
| 作者: Cenql 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-11-05 20:07:23 評論於 Review of the submission, submitted on 26th April 2021. Received opinions from 2 reviewers on 19th May, and it took until 9th June to make the revisions. It was notified as accepted on 22nd June, proofread on 24th June, and published online directly on 28th June. It is evident that the speed is related to the interest of the editors and reviewers in the manuscript's theme. (0) 讚！ | Cenql |
| 作者: Dayton 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-10-22 10:18:37 評論於 Journals that are less conspicuous in nuclear medicine, many people may not know it (0) 讚！ | Dayton |
| 作者: 云来琪华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-10-22 08:21:09 評論於 In nuclear medicine, there are some journals that are not very prominent, maybe many people do not know about them (0) 讚！ | 云来琪华 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
